Axsome Therapeutics, Inc. (AXSM)
NASDAQ: AXSM · Real-Time Price · USD
104.26
+2.61 (2.57%)
At close: Jun 24, 2025, 4:00 PM
104.00
-0.26 (-0.25%)
After-hours: Jun 24, 2025, 7:58 PM EDT

Axsome Therapeutics Stock Forecast

Stock Price Forecast

The 16 analysts that cover Axsome Therapeutics stock have a consensus rating of "Strong Buy" and an average price target of $170.5, which forecasts a 63.53% increase in the stock price over the next year. The lowest target is $105 and the highest is $216.

Price Target: $170.5 (+63.53%)
Analyst Consensus: Strong Buy
Target Low Average Median High
Price $105 $170.5 $176 $216
Change +0.71% +63.53% +68.81% +107.17%

Analyst Ratings

The average analyst rating for Axsome Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating Jan '25Feb '25Mar '25Apr '25May '25Jun '25
Strong Buy 766777
Buy 788889
Hold 000000
Sell 000000
Strong Sell 000000
Total 141414151516

Latest Forecasts

Analyst Firm Rating Rating Action Price Target Upside Date
RBC Capital
RBC Capital
Buy
Maintains
$193$186
Buy Maintains $193$186 +78.40% Jun 12, 2025
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$180
Strong Buy Reiterates $180 +72.65% Jun 10, 2025
Needham
Needham
Strong Buy
Maintains
$153$150
Strong Buy Maintains $153$150 +43.87% Jun 9, 2025
Oppenheimer
Oppenheimer
Buy
Initiates
$185
Buy Initiates $185 +77.44% Jun 3, 2025
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$180
Strong Buy Reiterates $180 +72.65% May 22, 2025
More Analyst Ratings

Financial Forecast

Revenue This Year
628.06M
from 385.69M
Increased by 62.84%
Revenue Next Year
1.01B
from 628.06M
Increased by 60.02%
EPS This Year
-3.57
from -5.99
EPS Next Year
1.72
from -3.57
Fiscal Year FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025 FY 2026 FY 2027
Period Ending Dec 31, 2020 Dec 31, 2021 Dec 31, 2022 Dec 31, 2023 Dec 31, 2024 Dec 31, 2025 Dec 31, 2026 Dec 31, 2027
Revenue
--50.04M270.60M385.69M628.06M1.01B1.54B
Revenue Growth
---440.80%42.53%62.84%60.02%52.84%
EPS
-2.77-3.47-4.60-5.27-5.99-3.571.729.60
EPS Growth
-------459.01%
Forward PE
------60.7010.86
No. Analysts
-----212117
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue 20252026202720282029
High 696.9M 1.2B 1.9B
Avg 628.1M 1.0B 1.5B
Low 569.6M 806.5M 1.1B

Revenue Growth

Revenue Growth 20252026202720282029
High
80.7%
85.5%
92.7%
Avg
62.8%
60.0%
52.8%
Low
47.7%
28.4%
14.0%

EPS Forecast

EPS 20252026202720282029
High -1.94 5.26 16.09
Avg -3.57 1.72 9.60
Low -4.36 -2.49 2.25

EPS Growth

EPS Growth 20252026202720282029
High - -
836.6%
Avg - -
459.0%
Low - -
31.2%
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.